We previously demonstrated that daily oral administration of high doses (67.5 mg) of insulin to children with a genetic risk of type 1 diabetes did not induce unwanted hypoglycaemia and was associated with the induction of low-affinity antibodies against insulin and insulin-responsive CD4+ T cells with features of regulation [24]. This evidence concerns the gene CD4 and type 1 diabetes mellitus.